Second line medication for Crohns disease

RX_CROHN_2NDLINE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AX|L01BB02

19425

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

16283

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

16283

diagram downward connector

Include endpoints None

16283

diagram downward connector
RX_CROHN_2NDLINE

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 15801 9851 5950
Unadjusted prevalence (%) 5.12 5.68 4.41
Mean age at first event (years) 50.72 49.93 52.04

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.36 [1.88, 2.95] 8.7e-14 772
15 years 0.01 1.55 [1.25, 1.92] 6.4e-5 415
5 years 0.00 3.18 [2.61, 3.88] 3.4e-30 260
1 year 0.00 3.27 [2.38, 4.50] 3.1e-13 51

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_CROHN_2NDLINE – Second line medication for Crohns disease
GWS hits: 13

Survival analyses between endpoints

Plot

before Second line medication for Crohns disease
after Second line medication for Crohns disease

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Second line medication for Crohns disease